• Sign In
  • Sign Out
  • My Account
Subscribe
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
  • Special reports
Clarivate
  • Data Snapshots
  • BioWorld
  • BioWorld MedTech
  • Infographics: Dynamic digital data analysis
  • Index insights
  • Special reports
  • Infographics: Dynamic digital data analysis
  • Trump administration impacts
  • Biopharma M&A scorecard
  • BioWorld 2024 review
  • BioWorld MedTech 2024 review
  • BioWorld Science 2024 review
  • Women's health
  • China's GLP-1 landscape
  • PFA re-energizes afib market
  • China CAR T
  • Alzheimer's disease
  • Coronavirus
  • More reports can be found here

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
Home » Newsletters » BioWorld Science

BioWorld Science

Oct. 3, 2000

View Archived Issues

Bristol-Myers Squibb and Lexicon team up for high-throughput genetic target validation

Read More

Telik awarded SBIR grant for new TRAP applications

Read More

MGI Pharma commences phase II liver cancer trial with irofulven

Read More

NIH grants anti-Notch-1 monoclonal antibody technology to Viragen

Read More

SangStat receives grant to fund studies of RDP-58 in primate model of HIV infection

Read More

Alkermes completes patient enrollment in clinical trial of new treatment for alcoholism

Read More

Antex Pharma and Lyotropic create joint antibiotic development program

Read More

Pfizer transfers anticancer compound to OSI; early trial results released

Read More

Rigel obtains rights to antiviral drug technologies from Questcor

Read More

Inhaled morphine in phase II for breakthrough pain

Read More

Thymitaq enters phase III for HCC

Read More

First approval for recombinant drug for infertility

Read More

Spanish group presents new CCK1 antagonists with anxiolytic-like effects in Alicante

Read More

Versicor identifies promising leads in new class of antibiotics: inhibitors of peptide deformylase

Read More

New class of oral TNF-alpha synthesis inhibitors presented at September conference

Read More

Dana-Farber reports SAR profile of novel class of antifolates

Read More

Novartis reports success in developing orally active dual MMP/TNF-alpha inhibitors

Read More

Keppra receives E.U. approval for treatment of epilepsy

Read More

Dual D2/beta2-adrenoceptor agonists in clinical development at AstraZeneca for respiratory diseases

Read More

FDA approves Fosamax for use in men with osteoporosis

Read More

Clinical safety and pharmacokinetics of ravuconazole discussed at ICAAC

Read More

Novel polypeptide with potential for diabetes Rx described by ZymoGenetics

Read More

Angiopoietin-related protein isolated at Regeneron

Read More

New benzaldehyde derivatives from Norsk Hydro suppress increased cell proliferation

Read More

Synthesis and use of new Sankyo compounds elevating [Ca2+]i levels described in recent patent

Read More

Anti-H. pylori agents prepared and tested at Welfide

Read More

Mevinolin derivatives for disorders mediated by LFA-1/ICAM-1 interactions

Read More

GGTase-inhibiting antifungal agents identified by Banyu

Read More

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for July 7, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for July 7, 2025.
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for July 1, 2025
  • Illustration of the β2-adrenergic receptor

    Exercise-mimicking compound offers alternative to GLP-1 therapies

    BioWorld
    An experimental drug for treating diabetes and obesity has been shown to lower blood sugar levels and increase fat burning. It is a β2-adrenergic receptor (β2AR)...
  • Deal handshake with coin, chart background

    After axing 95% workforce, Vor bets $4B+ on Remegen’s telitacicept

    BioWorld
    Just a month after laying off 147 employees and announcing plans to mull “strategic alternatives,” Vor Biopharma Inc. reported raising $175 million in private...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2025. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe